US EditionQSimulate Raises $11M For Quantum Drug Discovery Platform
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
QSimulate Raises $11M For Quantum Drug Discovery Platform
QSimulate, a startup pioneering quantum chemistry reformulations for drug discovery, has raised over $11 million in seed funding. The company’s quantum-powered platform, QUELO v2.3, aims to accelerate and improve the accuracy of simulating complex drug-protein interactions at a subatomic level.
QSimulate Raises New Financing and Launches QUELO v2.3 for Quantum-Powered Drug Discovery
QSimulate has announced an additional round of seed financing, bringing its total funding to date to over $11 million. The company, which focuses on quantum simulation technology for drug discovery, simultaneously announced QUELO v2.3, the latest generation of its quantum-powered simulation platform. QSimulate’s platform is built on a quantum mechanics approach to molecular modeling, designed [...] The post QSimulate Raises New Financing and Lau…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
